000			01983 a2200589 4500
005			20250516001607.0
264		0	_c20110624
008			201106s 0 0 eng d
022			_a1540-8167
024	7		_a10.1111/j.1540-8167.2010.01894.x _2doi
040			_aNLM _beng _cNLM
100	1		_aGautam, Sandeep
245	0	0	_aEffect of therapeutic INR on activated clotting times, heparin dosage, and bleeding risk during ablation of atrial fibrillation. _h[electronic resource]
260			_bJournal of cardiovascular electrophysiology _cMar 2011
300			_a248-54 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnticoagulants _xadministration & dosage
650	0	4	_aAtrial Fibrillation _xblood
650	0	4	_aBlood Coagulation _xdrug effects
650	0	4	_aBoston
650	0	4	_aCatheter Ablation _xadverse effects
650	0	4	_aChi-Square Distribution
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Monitoring _xmethods
650	0	4	_aFemale
650	0	4	_aHemorrhage _xblood
650	0	4	_aHeparin _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aInternational Normalized Ratio
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPredictive Value of Tests
650	0	4	_aRegression Analysis
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aWarfarin _xadministration & dosage
700	1		_aJohn, Roy M
700	1		_aStevenson, William G
700	1		_aJain, Rahul
700	1		_aEpstein, Laurence M
700	1		_aTedrow, Usha
700	1		_aKoplan, Bruce A
700	1		_aMcClennen, Seth
700	1		_aMichaud, Gregory F
773	0		_tJournal of cardiovascular electrophysiology _gvol. 22 _gno. 3 _gp. 248-54
856	4	0	_uhttps://doi.org/10.1111/j.1540-8167.2010.01894.x _zAvailable from publisher's website
999			_c20145972 _d20145972